News Focus
News Focus
Followers 2
Posts 172
Boards Moderated 0
Alias Born 02/15/2013

Re: biopharm post# 154265

Friday, 01/03/2014 12:23:57 AM

Friday, January 03, 2014 12:23:57 AM

Post# of 347009
Bio ......
Nobody is interested in PPHM , as they have nothing to offer at this point of time. Most BP will wait to see P3 data before stepping in .

P3 will get finance from a Fund in the exchange of preferred shares.

Investment funds seeks preferred share when they are worried about company future prospects.

Preferred share holder has priority over common shareholder.
WS funds are notorious to suck every single drop of common shareholder blood.

So , there is nothing to cheer about all the preferred share talk. The end result is dilution and suffering for common shareholder.

ws
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y